Calderón CJ

Language: Spanish
References: 20
Page: 58-62
PDF size: 102.77 Kb.

ABSTRACT

The understanding of the etiology of congenital heart disease is rapidly progressing from the recognition of embryologic origins to insight into the genetic basis for these disorders. Better understanding of the clinical implications of specific mutations should allow not only for more sensitive and specific diagnoses to be made but also for improvements in therapeutics options an efficacy. Mutations in the T-box transcription factor TBX5 cause Holt-Oram syndrome, an autosomal-dominant condition characterized by a familial history of congenital heart disease and upper limb defects. This review summarizes recent developments in the study of Holt-Oram Syndrome.

REFERENCES

1. D’Alton ME, DeCherney AH: Prenatal diagnosis. N Engl J Med 1993; 328: 114-120.

2. Bruneau BG: The developing heart and congenital heart defects: a make or break situation. Clin Genet 2003; 63: 252-261.

3. Lewin MB, Glass IA, Power P: Genotype-phenotype correlation in congenital heart disease. Curr Opin Cardiol 2004; 19: 221-227.

4. Velázquez Arellano A: El complejo problema de la relación entre el genotipo y el fenotipo. En Antonio Velázquez A. Lo que somos y el Genoma Humano. Ed. Fondo de Cultura Económica, México DF: 2004: 105-117.

5. Dipple KM, McCabe ER: Phenotypes of patients with “simple” Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics. Am J Human Genet 2000; 66: 1729-1735.

6. Roux-Rouquie M: Genetic and epigenetic regulation schemes: Need for an alternative paradigm. Mol Genet Metab 2000; 71: 1-9.

7. Pearson H: Surviving a knockout blow. Nature 2002; 415: 8-9

8. Barahona A, Piñero D: Genética. La continuidad de la vida. 3ª Edición. Fondo de Cultura Económico. México DF. 2002: 47-138.

9. Kuhn TS: La estructura de las revoluciones científicas. 4ª Edición. Fondo de Cultura Económica. Mexico DF. 2004.

10. Holt M, Oram S: Familiar heart disease with skeletal malformations. Br Heart J 1960: 22: 236-242.

11. Buendía A, Calderón-Colmenero J, Patiño E, Zabal C, Erdmenger J, Ramírez S, et al: Síndromes asociados a cardiopatías congénitas. PAC Pediatria-1. Academia Mexicana de Pediatría. Ed. Intersistemas. México. 2004: 569-571.

12. Ogar G, Gul D, Lenk MK: Variable clinical expression of Holt-Oram syndrome in three generations. Turk J Peddiatr 1998; 40: 613-618.

13. Cachat F, Rapatsalahy A, Sekarski N: Three different types of atrial septal defects in the same family. Arch Masl Coeur Vaiss. 1999; 92: 667-669.

14. Bossert T, Walther T, Gummer J, Hubald R, Kostelka R: Cardiac malformations associated with the Holt-Oram syndrome report on a family and review of the literature. J Thorac Cardiovasc Surg 2002; 59: 312-314.

15. Mori AD, Bruneau BG: TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 2004; 19: 211-215.

16. Brassington AM, Sung SS, Toydemir RM: Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 2003; 73: 74-85.

17. Bruneau BG, Nemer G, Schmitt JP: A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor TBX5 in cardiogenesis and disease. Cell 2001; 106: 709-721.

18. Bressan MC, McDermott DA, Spencer RH, Basson CT: TBX5 genetic testing validates strict clinical diagnostic criteria for Holt-Oram syndrome. Circulation 2003; 108(17): IV-358.

19. Kohhase J, Schubert L, Liebers M: Mutations at the SALL 4 locus on chromosome 20 results in a range of clinically overlapping phenotypes including Okhiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported thalidomide embryopathy. J Med Genet 2003; 40: 473-478.

20. Schott JJ, Benson DW, Basson CT: Congenital heart disease caused by mutations in the transcription factor Nkx2.5. Science 1998; 281: 108-11.